Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Optiray (ioversol injection),74%, 68%, 51% Mallinckrodt Medical, NDA 20-923 IOVERSOL Injection 34% OPTIRAY 160 Mallinckrodt | 019710 IOVERSOL Injection 51% OPTIRAY 240 Mallinckrodt | 020923 IOVERSOL Injection 64% OPTIRAY 300 Mallinckrodt | 019710 IOVERSOL Injection 64% OPTIRAY 300 Mallinckrodt | 019710 IOVERSOL Injection 68% OPTIRAY 320 Mallinckrodt | 020923 IOVERSOL Injection 74% OPTIRAY 350 Mallinckrodt | 019710 IOVERSOL Injection 74% OPTIRAY 350 Mallinckrodt | Optiray (Ioversol) Injection, Mallinckrodt, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com